0000950170-24-092733.txt : 20240807 0000950170-24-092733.hdr.sgml : 20240807 20240807160504 ACCESSION NUMBER: 0000950170-24-092733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240805 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Graul Regina Margaret CENTRAL INDEX KEY: 0002002981 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 241183537 MAIL ADDRESS: STREET 1: CYCLERION THERAPEUTICS, INC. STREET 2: 254 FIRST STREET, 18TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 ownership.xml 4 X0508 4 2024-08-05 0001755237 Cyclerion Therapeutics, Inc. CYCN 0002002981 Graul Regina Margaret C/O CYCLERION THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR CAMBRIDGE MA 02142 true true false false See Remarks false Stock Option (Right to Buy) 3.30 2024-08-05 4 A false 55849 0 A 2034-08-05 Common Stock 55849 55849 D The Reporting Person was granted an option to purchase up to 55,849 shares of the Corporation's common stock pursuant to the 2019 Equity Incentive Plan. These 55,849 shares vest ratably in monthly installments over a 48-month period commencing August 31, 2024 and ending July 31, 2028, provided that the Reporting Person remains employed by Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions. President and Chief Executive Officer /s/ Regina M. Graul 2024-08-07